Pinnacle Wealth Planning Services
LGND icon

Pinnacle Wealth Planning Services’s Ligand Pharmaceuticals LGND Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$128K Buy
411
+6
+1% +$1.77K 0.01% 725
2026
Q2 		$128K Buy
405
+9
+2% +$2.12K 0.01% 742
2026
Q1 		$79.1K Buy
396
+31
+8% +$6.13K 0.01% 934
2025
Q4 		$69K Buy
+365
New +$70.1K 0.01% 996

Other funds holding LGND

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Congress Asset Management
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return

Pinnacle Wealth Planning Services's LGND Position: Q3 2026 in Review

Pinnacle Wealth Planning Services increased its Ligand Pharmaceuticals (LGND) stake by 1.5% in Q3 2026, buying an estimated $1.77K and bringing the position to 411 shares worth $128K. The position accounts for 0.01% of the portfolio, ranked #725.

Pinnacle Wealth Planning Services first reported a position in LGND in Q4 2025 and has held it in 4 quarters since. 348 funds tracked by Wall St. Rank hold LGND as of Q3 2026.

  • Pinnacle Wealth Planning Services held 411 shares of Ligand Pharmaceuticals worth $128K as of Q3 2026.
  • Pinnacle Wealth Planning Services bought 6 Ligand Pharmaceuticals shares in Q3 2026, an estimated $1.77K.
  • Ligand Pharmaceuticals made up 0.01% of Pinnacle Wealth Planning Services's portfolio in Q3 2026, its #725 holding.
  • Pinnacle Wealth Planning Services first reported a position in Ligand Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • 348 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q3 2026, filed 27 Oct 2026.